You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KSHV Associated MCD

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

Not yet recruiting
  • KSHV Inflammatory Cytokine Syndrome (KICS)
  • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 2, 2023

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)

Recruiting
  • Viral Associated Malignancies
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 20, 2022

Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia Trial run by the NCI (Zidovudine, Tocilizumab,

Completed
Has Results
  • Castleman Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 8, 2020

Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
Mar 9, 2022

s From HIV Infection, KSHV Infection, Viral-Related

Recruiting
  • HIV
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

    Recruiting
    • Multicentric Castleman Disease
    • Lilongwe, Malawi
      UNC Project, Kamuzu Central Hospital
    May 2, 2022

    Risk Factors for Non-HIV-Related Kaposi s Sarcoma

    Completed
    • Kaposi's Sarcoma
      • Palermo, Italy
        Universita Degli Studi Di Palermo
      Mar 11, 2021

      Nephrotic Syndrome Study Network

      Recruiting
      • Minimal Change Disease (MCD)
      • +2 more
      • Kidney Biopsy
      • Los Angeles, California
      • +34 more
      Jan 3, 2022

      Focal Segmental Glomerulosclerosis and Minimal Change Disease

      Not yet recruiting
      • Focal Segmental Glomerulosclerosis
      • +3 more
      • Biospecimen collection
      • Data collection
      • Ann Arbor, Michigan
        University of Michigan
      Dec 6, 2022

      SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

      Completed
      • SARS-CoV Infection
      • +3 more
      • Moderna COVID-19 Vaccine
      • +2 more
      • Tucson, Arizona
      • +28 more
      Sep 19, 2022

      Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

      Recruiting
      • Glomerulosclerosis, Focal Segmental
      • +2 more
      • Biosampling
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Nov 12, 2021

      Classical Lissencephalies and Subcortical Band Heterotopias Trial in Jette (Venipuncture and skin biopsy for RNA extraction)

      Not yet recruiting
      • Classical Lissencephalies and Subcortical Band Heterotopias
      • Venipuncture and skin biopsy for RNA extraction
      • Jette, Brussel, Belgium
        UZ Brussel
      Jan 7, 2022

      Free Mucogingival Grafts, Gingival Recession, Root Coverage Trial in Murcia (Buccal muco-gingival tissue graft, Palatal

      Recruiting
      • Free Mucogingival Grafts
      • +3 more
      • Buccal muco-gingival tissue graft
      • Palatal connective tissue graft
      • Murcia, Spain
        Centro Odontologico Del Sureste Slp
      May 6, 2023

      Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

      Recruiting
      • Diffuse Large B Cell Lymphoma (DLBCL)
      • Orelabrutinib + R-CHOP
      • Placebo + R-CHOP
      • Shanghai, Shanghai, China
        Shanghai Ruijing Hospital
      Nov 28, 2022

      A Study of Rituximab in Frontline Therapy for Glomerulonephritis

      Recruiting
      • Glomerulonephritis
        • Shanghai, China
        • +4 more
        Feb 27, 2023

        Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +8 more
        • Ipilimumab
        • Nivolumab
        • La Jolla, California
        • +34 more
        Nov 29, 2022

        Kaposi Sarcoma Trial run by the NCI (Abemaciclib)

        Recruiting
        • Kaposi Sarcoma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

        Recruiting
        • Minimal Change Disease
        • Focal Segmental Glomerulosclerosis
        • Los Angeles, California
        • +7 more
        Jul 19, 2022

        Kaposi Sarcoma, Skin Trial in Los Angeles, Saint Louis (Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire

        Suspended
        • Kaposi Sarcoma
        • Skin
        • Ixazomib Citrate
        • +2 more
        • San Diego, California
        • +1 more
        Jan 30, 2023

        Kidney Diseases, Diabetic Nephropathies, Glomerulosclerosis, Focal Segmental Trial in United States (GFB-887, Placebo)

        Recruiting
        • Kidney Diseases
        • +10 more
        • Birmingham, Alabama
        • +75 more
        Mar 29, 2022

        Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)

        Completed
        • Kidney Disease
        • N-acetyl D-mannosamine
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Orelabrutinib in Combination With Standard Treatment Regimen for

        Not yet recruiting
        • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
        • Nanjing, Jiangsu, China
          Hematological Department, People's Hospital of Jiangsu Province
        Aug 23, 2023

        Understand Genetics and Clinical Course of Focal Segmental

        Terminated
        • Glomerulosclerosis, Focal Segmental
        • +2 more
        • FSGS/TR-MCD
        • Diabetic Nephropathy (DN)
        • Mesa, Arizona
        • +17 more
        Jul 17, 2021

        FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

        Recruiting
        • FSGS
        • +3 more
        • Ann Arbor, Michigan
        • +3 more
        Jan 31, 2022